Nanomedicine

The British Society for Nanomedicine (BSNM) is proud to collaborate with SELECTBIO in the organisation of Nanomedicine 2014. BSNM is a registered charity, created to allow open access for industry, academia, clinicians and the public to news and details of on-going nanomedicine research throughout the UK and beyond.

Agenda Topics:

- Aptamer Targeted Nanoparticles
- Cell and Particle Tracking
- Fundamental Study of Nanoparticle - Biological Interactions
- Nano Material Design
- Nanosuspensions
- siRNA and Biologicals
+ show speakers and program
Keynote Speakers:
-Kattesh Katti
Director, University of Missouri
-Steve Rannard
Group Leader & Vice Chair, University of Liverpool

Speakers:
-Andrew Owen, Professor, University of Liverpool
-Delphine Felder-Flesch, Researcher, Institut de Physique et Chimie des Materiaux de Strasbourg
-Vicki Stone, Director, Heriot-Watt University
-Mariarosa Mazza, Research Fellow, University of Manchester
-Konstantin Sokolov, Associate Professor, The University of Texas at Austin
-Jonathan Lovell, Assitant Professor, University at Buffalo
-Christine Dufes, Senior Lecturer in Drug Delivery, University of Strathclyde
-Marianne Ashford, Principal Scientist, Drug Targeting, AstraZeneca
-Eric Mayes, CEO, Endomagnetics
-Rosana Simon-Vazquez, Post-doctoral Researcher, University of Vigo
-Davide Moscatelli, Assitant Professor, Politecnico di Milano
-Olivier Fontaine, European Technology Platform on Nanomedicine (ETPN) Representative, Nanobiotix

26 Mar - 27 Mar 2014

Boston
United Kingdom
meeting website